BioPharmSignal logoBioPharmSignal

Biotech News

Tactile Medical to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 17, 2026

Tactile Systems Technology, Inc. (TCMD)Tactile Systems Technology, Inc.2026-06-25 13:46 ESTEarnings

MINNEAPOLIS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2025 financial results will be

Open original release

Related news

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Medical to Present at the Piper Sandler 37th Annual Healthcare Conference

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Medical Strengthens Board of Directors with Appointment of Andrea Pearson

TCMDTactile Systems Technology, Inc.2026-06-25 13:46 EST

Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results

View all latest news

Tactile Systems Technology, Inc.

Tactile Systems Technology is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.

Recent company news

TCMDTactile Systems Technology, Inc.2026-06-26 09:46 EST

Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy

TCMDTactile Systems Technology, Inc.2026-06-26 09:46 EST

Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference

TCMDTactile Systems Technology, Inc.2026-06-26 09:46 EST

Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025

TCMDTactile Systems Technology, Inc.2026-06-26 09:46 EST

Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema

TCMDTactile Systems Technology, Inc.2026-06-26 09:46 EST

Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
Biotechnology
Location
United States